M&A Deal Summary

Azulis Capital and Rivean Capital Acquire Novasep

On January 22, 2007, private equity firms Azulis Capital and Rivean Capital acquired life science company Novasep for 425M USD

Acquisition Highlights
  • This is Azulis Capital’s 4th and Rivean Capital’s 1st transaction in the Life Science sector.
  • This is Azulis Capital’s and Rivean Capital’s 2nd largest (disclosed) transaction.
  • This is Azulis Capital’s 38th and Rivean Capital’s 1st transaction in France.
Investment Fate
  • Novasep merged with another company in 2022.

M&A Deal Summary
Date 2007-01-22
Target Novasep
Sector Life Science
Buyer(s) Azulis Capital
Rivean Capital
Deal Type Buyout (LBO, MBO, MBI)
Deal Value 425M USD

Target

Novasep

Lyon, France
Novasep provides cost-effective solutions for the sustainable production of molecules for the life sciences. Novasep offers a comprehensive range of services including process development, turnkey purification systems and contract manufacturing. The company specializes in challenging active molecules for pharmaceutical, biopharmaceutical, fine chemical, food and functional ingredients, as well as fermentation and chemical commodities industries. Novasep is based in Lyon, France.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 2

Buyer

Azulis Capital

Paris, France

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2000
PE ASSETS 1.0B EUR
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Azulis Capital is a private equity investment firm that targets buyout, recapitalization, and growth capital investments in France. Azulis looks to invest in mid-sized businesses with €20 to €120 million in enterprise value. Sectors of interest include consumer products and services, manufacturing, communications, healthcare, and chemicals. Azulis generally seeks to commit between €7 and €30 million per transaction. Azulis Capital was formerly known as Banexi Capital and is based in Paris.

DEAL STATS #
Overall 38 of 79
Sector (Life Science) 4 of 5
Type (Buyout (LBO, MBO, MBI)) 21 of 44
Country (France) 38 of 78
Year (2007) 4 of 8
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-01-01 Slota

93210, France

Slota is a provider of rental cars, taxi licenses, and other services and leases fleet of taxi vehicles. Slota was founded in 1932 and is based in Saint Deni, France.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-01-26 Lampe Berger SA

Bourgtheroulde, France

Lampe Berger SA provider of an air care products for houses and hospitals worldwide. Lampe Berger was founded in 1888 and is based in Bourgtheroudle, France.

Buy -
Buyer

Rivean Capital

Amsterdam, Netherlands

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1982
PE ASSETS 5.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Gilde Buy Out Partners (GBO) is unit of Gilde Investment Management, a Dutch private equity group. Gilde Buy Out Partners (GBO) targets investments in larger businesses valued from €75 and €600 million with at least €8 million in cash flow. Broad sectors of interest include services, consumer goods, manufacturing, and industrial products. GBO looks for investments across Western Europe, with an emphasis on opportunities in Belgium, The Netherlands, Luxembourg, France, Germany, Switzerland and Austria. Gilde was formed in 1982 and has offices in Utrecht, Paris, Brussels, and Zurich.

DEAL STATS #
Overall 20 of 76
Sector (Life Science) 1 of 3
Type (Buyout (LBO, MBO, MBI)) 12 of 28
Country (France) 1 of 1
Year (2007) 1 of 5
Size (of disclosed) 2 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-11-28 CABB

Sulzbach am Taunus, Germany

CABB is a vertically integrated global supplier of fine and specialty chemicals and customer manufacturing solutions for the agrochemicals, pharmaceuticals, personal care, and food markets. CABB was founded in 2003 and is based in Sulzbach am Taunus, Germany.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-04-18 Norit Activated Carbon

Amersfoort, Netherlands

Norit Activated Carbon is a supplier of purification technologies primarily serving the water and beverage markets, offering components and systems for every part of the water value chain. Norit Activated Carbon was founded in 1918 and is based in Amersfoort, Netherlands.

Sell $351M
Mergr

Product

Company

Legal